To include your compound in the COVID-19 Resource Center, submit it here.

New IPO filings include NGM, Arog, Gamida

Three more biotechs filed late Friday to go public on NASDAQ, adding new companies to a 2018 class of IPOs that could surpass 2015's record for funds raised. The group includes NGM Biopharmaceuticals Inc. (South San Francisco, Calif.), Arog Pharmaceuticals Inc. (Dallas, Texas) and Gamida Cell Ltd. (Jerusalem, Israel) (see "Paper Chase").

NGM, a liver disease

Read the full 556 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE